| Stage | WFRD | % of rev | ALAB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $392M | 100.00% | WFRD ×2.91 |
| Gross profit | $374M | 32.72% | $288M | 73.28% | ALAB +40.6pp |
| Operating income | $153M | 13.39% | $89M | 22.74% | ALAB +9.4pp |
| Pre-tax income | $129M | 11.29% | $103M | 26.20% | ALAB +14.9pp |
| Net income | $125M | 10.94% | $153M | 39.01% | ALAB +28.1pp |
| Stage | WFRD | ALAB | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $392M100.00% | WFRD ×2.91 |
| Gross profit | 32.72%$374M | 73.28%$288M | ALAB +40.6pp |
| Operating income | 13.39%$153M | 22.74%$89M | ALAB +9.4pp |
| Pre-tax income | 11.29%$129M | 26.20%$103M | ALAB +14.9pp |
| Net income |
| 10.94%$125M |
| 39.01%$153M |
| ALAB +28.1pp |